Product NDC: | 55390-339 |
Proprietary Name: | Dacarbazine |
Non Proprietary Name: | Dacarbazine |
Active Ingredient(s): | 200 mg/20mL & nbsp; Dacarbazine |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-339 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075812 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080303 |
Package NDC: | 55390-339-10 |
Package Description: | 10 VIAL in 1 BOX (55390-339-10) > 20 mL in 1 VIAL |
NDC Code | 55390-339-10 |
Proprietary Name | Dacarbazine |
Package Description | 10 VIAL in 1 BOX (55390-339-10) > 20 mL in 1 VIAL |
Product NDC | 55390-339 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dacarbazine |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20080303 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | DACARBAZINE |
Strength Number | 200 |
Strength Unit | mg/20mL |
Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |